Also within the replication population, SDFR incidence was highest among ACPA-negative RA patients with high baseline CRP levels (> 3× ULN) and early DAS remission, respectively 87% compared to ~ 52% in the other two groups (p = 0.03, Fig. 6B). This evidence concerns the gene PRTN3 and rheumatoid arthritis.